Evaluating the Complementary Nature of Randomized Controlled Trials and Real-World Evidence Using Over 5 Years of Experience with Fremanezumab: A Narrative Review
Piero Barbanti, Timothy Smith, Verena Ramirez Campos, Alejandra Elizabeth Guevara Morel, Caroline Ling, Preet Bhogal, Caoimhe Leonard, Richard James Stark
Springer Nature ·
2026-06-17
· DOI 10.1007/s12325-026-03647-8
The publisher did not provide an abstract — full text is available via the link below.
Piero Barbanti, Timothy Smith, Verena Ramirez Campos, Alejandra Elizabeth Guevara Morel, Caroline Ling, Preet Bhogal et al. Evaluating the Complementary Nature of Randomized Controlled Trials and Real-World Evidence Using Over 5 Years of Experience with Fremanezumab: A Narrative Review. // Advances in Therapy. – 2026. – DOI: 10.1007/s12325-026-03647-8. – URL: https://doi.org/10.1007/s12325-026-03647-8
Piero Barbanti, Timothy Smith, Verena Ramirez Campos, Alejandra Elizabeth Guevara Morel, Caroline Ling, Preet Bhogal, Caoimhe Leonard, & Richard James Stark (2026). Evaluating the Complementary Nature of Randomized Controlled Trials and Real-World Evidence Using Over 5 Years of Experience with Fremanezumab: A Narrative Review. Advances in Therapy. https://doi.org/10.1007/s12325-026-03647-8
Piero Barbanti, et al. “Evaluating the Complementary Nature of Randomized Controlled Trials and Real-World Evidence Using Over 5 Years of Experience with Fremanezumab: A Narrative Review.” Advances in Therapy, 2026. doi:10.1007/s12325-026-03647-8.
@article{Barbanti2026,
title = {Evaluating the Complementary Nature of Randomized Controlled Trials and Real-World Evidence Using Over 5 Years of Experience with Fremanezumab: A Narrative Review},
author = {Barbanti, Piero and Smith, Timothy and Campos, Verena Ramirez and Morel, Alejandra Elizabeth Guevara and Ling, Caroline and Bhogal, Preet and Leonard, Caoimhe and Stark, Richard James},
journal = {Advances in Therapy},
year = {2026},
doi = {10.1007/s12325-026-03647-8},
url = {https://doi.org/10.1007/s12325-026-03647-8}
}